Acrivon Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing precision medicines through its innovative Generative Phosphoproteomics AP3 platform. This platform allows for an unbiased interpretation and quantification of drug-regulated pathway activity within cells, enabling the rapid design of differentiated compounds. With a rich data set and unique analytical tools, Acrivon is poised to streamline drug development and advance groundbreaking therapies into the clinic.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching